Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques
- 19 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 88 (4) , E330-E335
Abstract
BACKGROUND: Hypopituitarism is the most frequent complication after pituitary adenoma stereotactic radiosurgery (SRS) and is correlated with increasing radiation to the pituitary gland. Biological effective dose (BED) is a dosimetric parameter that incorporates a time component to adjust for mechanisms of deoxyribonucleic acid repair activated during treatment.OBJECTIVE: To assess mean gland BED as a predictor of post-SRS hypopituitarism, as compared to mean gland dose, in a contemporary cohort study of patients undergoing single-fraction SRS for pituitary adenoma.METHODS: Cohort study of 97 patients undergoing single-fraction SRS from 2007 to 2014. Eligible patients had no prior pituitary irradiation, normal pre-SRS endocrine function, and >24 mo of endocrine follow-up. Cox proportional hazards analysis was used to assess mean gland dose and BED as predictors of new post-SRS hypopituitarism.RESULTS: Median post-SRS follow-up was 48 mo (interquartile range [IQR], 34-68). A total of 27 patients (28%) developed new hypopituitarism at a median 22 mo (IQR, 12-36). Actuarial rates of new endocrinopathy were 17% at 2 yr (95% CI 10%-25%) and 31% at 5 yr (95% CI 20%-42%). On univariate analysis, sex (P = .02), gland volume (P = .03), mean gland dose (P < .0001), and BED significantly predicted new hypopituitarism (P < .0001). After adjusting for sex and gland volume, BED > 45 Gy2.47and mean gland dose > 10 Gy were significantly associated increased risk of hypopituitarism (hazard ratio [HR] = 14.32, 95% CI = 4.26-89.0,P < .0001; HR = 11.91, 95% CI = 3.54-74.0,P < .0001).CONCLUSION: BED predicted hypopituitarism more reliably than mean gland dose after pituitary adenoma SRS, but additional studies are needed to confirm these results.Keywords
This publication has 16 references indexed in Scilit:
- Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long‐term risk of hypopituitarismClinical Endocrinology, 2015
- The role of the concept of biologically effective dose (BED) in treatment planning in radiosurgeryPhysica Medica, 2015
- Dose-Volume Analysis of Radiation-Induced Optic Neuropathy After Single-Fraction Stereotactic RadiosurgeryNeurosurgery, 2014
- Descriptive epidemiology of pituitary tumors in the United States, 2004–2009Journal of Neurosurgery, 2014
- Long-term Evaluation of Radiation-Induced Optic Neuropathy After Single-Fraction Stereotactic RadiosurgeryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapyJournal of Neuro-Oncology, 2013
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009Neuro-Oncology, 2012
- Incidental pituitary adenomasNeurosurgical Focus, 2011
- Radiosurgery of growth hormone–producing pituitary adenomas: factors associated with biochemical remissionJournal of Neurosurgery, 2007
- Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalizationJournal of Neurosurgery, 2002